Genome-wide cell-free DNA fragmentation in patients with cancerStephen Cristiano, Victor E. Velculescu, Sarah Østrup Jensen et al.|Nature|2019Cited by 1.5k
Deficient mismatch repair system in patients with sporadic advanced colorectal cancerMiriam Koopman, J. Han van Krieken|British Journal of Cancer|2009Cited by 518
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysisLinda M. Henricks, Jan H.M. Schellens, Carin A.T.C. Lunenburg et al.|The Lancet Oncology|2018Cited by 419
ESMO Guidance for Reporting Oncology real-World evidence (GROW)Luís Castelo-Branco, Miriam Koopman, Anna Pellat et al.|Annals of Oncology|2023Cited by 209
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer GroupMarinde J. G. Bond, Johanneke H.M.J.V. Vestjens, Karen Bolhuis et al.|The Lancet Oncology|2023Cited by 168